AAAAAA
Results: 1-25/37
Authors:
KOFF RS
Citation: Rs. Koff, CHRONIC HEPATITIS-C - EARLY INTERVENTION, Hospital practice, 33(6), 1998, pp. 101
Authors:
KEEFFE EB
IWARSON S
MCMAHON BJ
LINDSAY KL
KOFF RS
MANNS M
BAUMGARTEN R
WIESE M
FOURNEAU M
SAFARY A
CLEMENS R
KRAUSE DS
Citation: Eb. Keeffe et al., SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Hepatology, 27(3), 1998, pp. 881-886
Authors:
KOFF RS
Citation: Rs. Koff, HEPATITIS-A, Lancet, 351(9116), 1998, pp. 1643-1649
Authors:
KOFF RS
Citation: Rs. Koff, SHOULD HEALTH-CARE WORKERS EXPOSED TO HEPATITIS-C ROUTINELY RECEIVE HEPATITIS-A VACCINE, JAMA, the journal of the American Medical Association, 279(3), 1998, pp. 195-195
Authors:
LASZLO A
KELLY JP
KAUFMAN DE
SHEEHAN JE
RETSAGI G
WIHOLM BE
KOFF RS
SUNDSTROM A
SHAPIRO S
Citation: A. Laszlo et al., CLINICAL ASPECTS OF UPPER GASTROINTESTINAL-BLEEDING ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS, The American journal of gastroenterology, 93(5), 1998, pp. 721-725
Authors:
KOFF RS
Citation: Rs. Koff, INTERFERON-ALPHA IN HEPATITIS-C, PharmacoEconomics, 11(5), 1997, pp. 491-491
Authors:
KOFF RS
Citation: Rs. Koff, THERAPY OF HEPATITIS-C - COST-EFFECTIVENESS ANALYSIS, Hepatology, 26(3), 1997, pp. 152-155
Authors:
SIMON DM
GORDON SC
KAPLAN AM
KOFF RS
REGENSTEIN F
EVERSON G
LEE YM
WEINER F
SILVERMAN A
PLASSE T
FEDORCZYK D
LIAO MJ
Citation: Dm. Simon et al., TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON ALFA-N3 - A MULTICENTER, RANDOMIZED, OPEN-LABEL TRIAL, Hepatology, 25(2), 1997, pp. 445-448
Authors:
KOFF RS
Citation: Rs. Koff, INTERFERON-ALPHA FOR CHRONIC HEPATITIS-C - REDUCING THE UNCERTAINTIES, Annals of internal medicine, 127(10), 1997, pp. 918-920
Authors:
KOFF RS
Citation: Rs. Koff, HEPATITIS-A VACCINE, Infectious diseases in clinical practice, 5(2), 1996, pp. 122-125
Authors:
BENNETT WG
WONG JB
KOFF RS
ISHIDA H
BECK JR
PAUKER SG
Citation: Wg. Bennett et al., WHAT IS THE OPTIMAL PRETREATMENT EVALUATION OF CHRONIC HEPATITIS-C, Hepatology, 24(4), 1996, pp. 1029-1029
Authors:
KELLY JP
KAUFMAN DW
JURGELON JM
SHEEHAN J
KOFF RS
SHAPIRO S
Citation: Jp. Kelly et al., RISK OF ASPIRIN-ASSOCIATED MAJOR UPPER-GASTROINTESTINAL BLEEDING WITHENTERIC-COATED OR BUFFERED PRODUCT, Lancet, 348(9039), 1996, pp. 1413-1416
Authors:
KEEFFE EB
MCMAHON BJ
KOFF RS
LINDSAY KL
MANNS M
IVARSON S
BAUMGARTEN R
WIESE M
KRAUSE DS
FOURNEAU M
SAFARY A
CLEMENS R
Citation: Eb. Keeffe et al., SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Gastroenterology, 110(4), 1996, pp. 1231-1231
Authors:
WONG JB
PAUKER SG
KOFF RS
Citation: Jb. Wong et al., INTERFERON FOR CHRONIC HEPATITIS-B - RESPONSE, Annals of internal medicine, 124(2), 1996, pp. 277-277
Authors:
KOFF RS
Citation: Rs. Koff, THERAPY IN CHRONIC HEPATITIS-C - SAY GOODBYE TO THE 6-MONTH INTERFERON REGIMEN, The American journal of gastroenterology, 91(10), 1996, pp. 2072-2074
Authors:
BROOKMAN RR
KOFF RS
SCHAFFNER W
MARGOLIS HS
COLLINS M
BLOOM BS
COUPEY SM
Citation: Rr. Brookman et al., CRITICAL ISSUES SURROUNDING HEPATITIS-B VACCINATION FOR ADOLESCENTS -A ROUND-TABLE, Journal of adolescent health, 17(4), 1995, pp. 208-233
Authors:
KOFF RS
DIENSTAG JL
Citation: Rs. Koff et Jl. Dienstag, EXTRAHEPATIC MANIFESTATIONS OF HEPATITIS-C AND THE ASSOCIATION WITH ALCOHOLIC LIVER-DISEASE, Seminars in liver disease, 15(1), 1995, pp. 101-109
Authors:
KOFF RS
SEEFF LB
Citation: Rs. Koff et Lb. Seeff, ECONOMIC MODELING OF TREATMENT IN CHRONIC HEPATITIS-B AND CHRONIC HEPATITIS-C - PROMISES AND LIMITATIONS, Hepatology, 22(6), 1995, pp. 1880-1882
Authors:
GORDON SC
EVERSON G
MCHUTCHINSON JG
REINUS J
REGENSTEIN F
KAPLAN MM
KOFF RS
FEDORCZYK D
PLASSE T
Citation: Sc. Gordon et al., NATURAL ALFA INTERFERON (ALFERON(R)-N) TREATMENT OF CHRONIC HEPATITIS-C IN PATIENTS REFRACTORY TO RECOMBINANT INTERFERON-ALFA-2B, Hepatology, 22(4), 1995, pp. 41-41
Authors:
SIMON DM
GORDON SC
KAPLAN MM
KOFF RS
REGENSTEIN F
EVERSON G
WEINER F
PLASSE T
FEDORCZYK D
Citation: Dm. Simon et al., NATURAL ALFA INTERFERON (ALFERON-(R)-N) TREATMENT OF CHRONIC HEPATITIS-C IN PREVIOUSLY UNTREATED PATIENTS, Hepatology, 22(4), 1995, pp. 180-180
Authors:
KOFF RS
Citation: Rs. Koff, HERBAL HEPATOTOXICITY - REVISITING A DANGEROUS ALTERNATIVE, JAMA, the journal of the American Medical Association, 273(6), 1995, pp. 502-502
Authors:
KOFF RS
Citation: Rs. Koff, GASTROENTEROLOGY AND HEPATOLOGY, JAMA, the journal of the American Medical Association, 273(21), 1995, pp. 1679-1680
Authors:
KOFF RS
Citation: Rs. Koff, SEROEPIDEMIOLOGY OF HEPATITIS-A IN THE UNITED-STATES, The Journal of infectious diseases, 171, 1995, pp. 19-23
Authors:
HOLLINGER FB
EICKHOFF T
GERSHON A
JONG EC
KOFF RS
ANDRE FE
MARCUS LC
MELNICK JL
KRUGMAN S
WOLFE MS
STEFFEN R
GREENBAUM JJ
STAPLETON JT
KRAUSE DS
CLEMENS R
Citation: Fb. Hollinger et al., DISCUSSION - WHO SHOULD RECEIVE HEPATITIS-A VACCINE - A STRATEGY FOR CONTROLLING HEPATITIS-A IN THE UNITED-STATES, The Journal of infectious diseases, 171, 1995, pp. 73-77
Authors:
KOFF RS
CORMIER M
BUCKMINSTER M
Citation: Rs. Koff et al., A SCHOOL-BASED CATCH-UP HEPATITIS-B VACCINATION PROGRAM IN FRAMINGHAM, MASSACHUSETTS, Gastroenterology, 108(4), 1995, pp. 1101-1101